Get my own profile
Public access
View all37 articles
5 articles
available
not available
Based on funding mandates
Co-authors
- Prof. Gerard JP van WestenPI Computational Drug Discovery (Professor AI & Med Chem, Leiden University)Verified email at gjpvanwesten.nl
- Alexey "Alex" LugovskoyEIR, Atlas VentureVerified email at lugovskoy.org
- Andreas BenderUniversity of Cambridge; Pangea Bio; Universitatea Babeș-Bolyai; UMF ClujVerified email at cam.ac.uk
- Gary TresadernComputational chemistry, Johnson & Johnson Innovative MedicineVerified email at its.jnj.com
- Jörg Kurt WegnerDirector, In Silico Discovery, Janssen R&D, Cambridge, MA, USVerified email at its.jnj.com
- Laura Perez-BenitoSenior Scientist Computational Chemistry JanssenVerified email at its.jnj.com
- Eelke Bart LenselinkGalapagosVerified email at glpg.com
- Woody ShermanPsivant TherapeuticsVerified email at psivant.com
- Lindsey BurggraaffLeiden UniversityVerified email at lacdr.leidenuniv.nl
- Thijs BeumingLatham Biopharm GroupVerified email at lathambiopharm.com
- John P. OveringtonCTO, ExscientiaVerified email at exscientia.co.uk
- Andrej SaliUniversity of California, San FranciscoVerified email at salilab.org
- Michael T.M. Emmerich (Dr. rer. nat.)Professor in Multiobjective OptimizationVerified email at liacs.nl
- PV CoveneyUCLVerified email at ucl.ac.uk
- Bert UW Maesgewoon hoogleraarVerified email at uantwerpen.be
- Ivet BaharDirector, Laufer Center for Physical & Quantitative Biology, Stony Brook UniversityVerified email at pitt.edu
- Thomas HankemeierProfessor of Analytical Biosciences, Leiden UniversityVerified email at lacdr.leidenuniv.nl
- Eelke van der HorstThe HyveVerified email at thehyve.nl
- Julio E. PeironcelyPhD student at Leiden UniversityVerified email at chem.leidenuniv.nl
- Berthold WroblowskiSenior scientist,Janssen, Pharmaceutical Companies of Johnson and JohnsonVerified email at its.jnj.com